Similar to AML, CML, and CLL, blockage of the CXCR4/CXCL12 pathway by AMD3100 is also being investigated in multiple myeloma and other hematopoietic cancers. This evidence concerns the gene CXCR4 and chronic myelogenous leukemia, BCR-ABL1 positive.